decisionhealth Newsletters, Coder Pink Sheets - 2005 Issue 5 (May)
Drug administration codes: New sequential IV code incorrectly bundled into five drug admin codes, including G0359 used for Remicade
Subscribe or sign in to view the full article.
Article Overview
This article covers a Medicare National Correct Coding Initiative issue involving sequential intravenous drug administration reporting and related HCPCS drug administration codes. It is aimed at coders, billing staff, and clinicians who submit infusion claims, especially those working with chemotherapy and other IV drug administration services. The discussion focuses on the temporary edit problem, the planned update timing, and the general use of a modifier to bypass the affected claim edits until the correction becomes effective.
Why This Topic Matters
It matters because the article describes a temporary claims-processing edit that can affect reimbursement and claim acceptance for infusion services. Readers need to know the general nature of the issue, the timing of the update, and the categories of services impacted so they can recognize whether their claims are likely to be affected.
What You Will Learn
- The scope of a Medicare edit affecting sequential IV drug administration claims
- How the article frames the timing of the National Correct Coding Initiative update
- Which broad categories of infusion-related services are discussed
- Why the article is relevant to infusion billing and claim submission workflows
Who Should Read This
- Medical coders
- Billing specialists
- Revenue cycle staff
- Gastroenterology practices
- Oncology practices
- Infusion centers
Codes Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com